muscoril
Commercial- Indications
- Musculoskeletal disorders
Company intelligence / Profile preview
DOC Pharma
Milan, Italydocpharma.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
DOC Pharma is an established Italian pharmaceutical company with a portfolio of over 250 molecules and approximately 700 SKUs covering all main therapeutic areas. The company ranks eighth in terms of value in the Italian pharmaceutical market with 2023 ex-factory revenue of 299 million euros, and is second in the Class A equivalent drug market[1].
- Therapeutic areas
- RheumatologyOphthalmologyNeurology
- Modalities
- Generic drugsbranded productsnutraceuticals
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on DOC Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DOC Pharma.